Quick links
Activities
Cannabis policy: recent developments
COVID-19 and drugs
Document Library
Drug profiles
Drugs and the darknet
EMCDDA 25 years
EU Drug Markets Report
European Drug Report
European Responses Guide
Key epidemiological indicators
Lisbon addictions
Media library
New psychoactive substances (NPS)
Partners
Policy evaluation
Statistical Bulletin
Web archive of the EMCCDA (WayBack)
Toggle navigation
Toggle search form
GO
Results hosted on duckduckgo.com
Data
Countries
Topics
Best practice
Publications
Events
News
About
Home
amphetamine
Show/hide filters
Filter by
(-)
Remove Keywords: drug-checking filter
Keywords: drug-checking
(-)
Remove Keywords: drug situation filter
Keywords: drug situation
(-)
Remove Keywords: naloxone filter
Keywords: naloxone
(-)
Remove Keywords: law filter
Keywords: law
(-)
Remove Keywords: cyclopropylfentanyl filter
Keywords: cyclopropylfentanyl
(-)
Remove Keywords: hepatitis C filter
Keywords: hepatitis C
(-)
Remove Keywords: OAT (opioid agonist treatment) filter
Keywords: OAT (opioid agonist treatment)
(-)
Remove Keywords: price filter
Keywords: price
(-)
Remove Keywords: homelessness filter
Keywords: homelessness
(-)
Remove Keywords: societal impact filter
Keywords: societal impact
(-)
Remove Keywords: treatment provision filter
Keywords: treatment provision
(-)
Remove Keywords: young people filter
Keywords: young people
Keywords
Keywords
(-)
Remove cyclopropylfentanyl filter
cyclopropylfentanyl
(-)
Remove drug-checking filter
drug-checking
(-)
Remove drug situation filter
drug situation
(-)
Remove hepatitis C filter
hepatitis C
(-)
Remove homelessness filter
homelessness
(-)
Remove law filter
law
(-)
Remove naloxone filter
naloxone
(-)
Remove OAT (opioid agonist treatment) filter
OAT (opioid agonist treatment)
(-)
Remove price filter
price
(-)
Remove societal impact filter
societal impact
(-)
Remove treatment provision filter
treatment provision
(-)
Remove young people filter
young people
amphetamine
Go
Reset
No results found. Try a different search term.
.
Loading
